Molecular Heterogeneity of -Thalassemia Alleles in Spain and its Importance in the Diagnosis and Prevention of -Thalassemia Major and Sickle Cell Disorders

被引:11
|
作者
Manu Pereira, Maria del Mar
Cabot Dalmau, Anna
Vives Corrons, Joan-Lluis
机构
[1] Red Cell Pathology Unit, Hospital Clínic I Provincial, University of Barcelona
[2] Pediatrics Service, Hospital de Mataró, Barcelona
关键词
-Thalassemia (-thal); Sickle cell disorders; Molecular heterogeneity; Prenatal diagnosis; BETA-THALASSEMIA; G6PD DEFICIENCY; DISEASE; HEMOGLOBINOPATHIES; POPULATIONS; HEMATOLOGY; FREQUENCY; DNA;
D O I
10.1080/03630260903089003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the last 20 years, migratory flows have changed the pattern of -thalassemia (-thal) mutations in Catalonia and have also increased S prevalence, either alone or in association with -thal alleles. Characterization of the gene is needed for genetic counseling for -thal major and also for sickle cell diseases. The purpose of this study was to investigate the current distribution pattern of -thal mutations. Seventy nine individuals were characterized at the molecular level. As a first step, frequent mutations in the Mediterranean region were screened and when none of these mutations were identified, the -globin gene was sequenced. Screening for common mutations allowed the characterization of 60 individuals. In the remaining 19 cases, 11 different mutations were identified. -Thalassemia heterogeneity in Spain has markedly increased, leading to the requirement of including new methods for genetic diagnosis. Prevention of -thal major and sickle cell disease are necessary since their prevalence in Spain is increasing dramatically.
引用
收藏
页码:226 / 234
页数:9
相关论文
共 50 条
  • [1] Prevention of the major thalassemia syndromes in Spain.: Prenatal diagnosis
    Ropero, P
    González, FA
    Briceño, O
    Benavente, C
    Mateo, M
    Muñoz, J
    Raños, R
    Barchín, M
    León, A
    Villegas, A
    BLOOD, 2002, 100 (11) : 31B - 32B
  • [2] PREVENTION OF THALASSEMIA MAJOR BY ANTENATAL DIAGNOSIS
    MODELL, B
    ANGASTINIOTIS, MA
    FAIRWEATHER, DVI
    MATZABIO, M
    WARD, RHT
    ARCHIVES OF DISEASE IN CHILDHOOD, 1979, 54 (12) : 972 - 973
  • [3] Trends in molecular diagnosis and therapy of β-thalassemia and sickle cell anemia -: Preface
    Fibach, E
    Gambari, R
    MINERVA BIOTECNOLOGICA, 2003, 15 (02) : 91 - 91
  • [4] Prenatal Molecular Diagnosis of β-Thalassemia and Sickle Cell Anemia in the Syrian Population
    Murad, Hossam
    Moassas, Faten
    Jarjour, Rami
    Mukhalalaty, Yasser
    Al-Achkar, Walid
    HEMOGLOBIN, 2014, 38 (06) : 390 - 393
  • [5] Side effects of hydroxyurea in patients with Thalassemia major and thalassemia intermedia and sickle cell anemia
    Ghasemi, A.
    Keikhaei, B.
    Ghodsi, R.
    IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2014, 4 (03) : 114 - 117
  • [6] SICKLE-CELL-ANEMIA, SICKLE-CELL BETA-THALASSEMIA, AND THALASSEMIA MAJOR IN ALBANIA - CHARACTERIZATION OF MUTATIONS
    BOLETINI, E
    SVOBODOVA, M
    DIVOKY, V
    BAYSAL, E
    CURUK, MA
    DIMOVSKI, AJ
    LIANG, R
    ADEKILE, AD
    HUISMAN, THJ
    HUMAN GENETICS, 1994, 93 (02) : 182 - 187
  • [7] Delay in Diagnosis of Hemoglobulinopathies (Thalassemia, Sickle Cell Anemia): A Need for Management of Thalassemia Programs
    Hassanzadeh, Jafar
    Mirahmadizadeh, Alireza
    Karimi, Mehran
    Rezaeian, Shahab
    IRANIAN JOURNAL OF PEDIATRICS, 2017, 27 (02)
  • [8] INTRAUTERINE DIAGNOSIS OF SICKLE-CELL ANEMIA AND THALASSEMIA
    KAN, YW
    ALTER, BP
    DOZY, AM
    NATHAN, DG
    FRIGOLET.FD
    PEDIATRIC RESEARCH, 1972, 6 (04) : 431 - &
  • [9] Major Challenges for Gene Therapy of Thalassemia and Sickle Cell Disease
    Papanikolaou, Eleni
    Anagnou, Nicholas P.
    CURRENT GENE THERAPY, 2010, 10 (05) : 404 - 412
  • [10] Thalassemia Major and Sickle Cell Disease in Adolescents and Young Adults
    Yacobovich, Joanne
    Tamary, Hannah
    ACTA HAEMATOLOGICA, 2014, 132 (3-4) : 340 - 347